GUAIFENESIN EXTENDE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded Contract SPE2DP26F7826 to DMS PHARMACEUTICAL GROUP INC with a total value of $216.48, issued on July 21, 2026, under the master delivery order SPE2DX25D9900. The contract pertains to the supply of GUAIFENESIN EXTENDE, identified by NSN 6505013405446 and PR 7017574826, intended for federal use through the Department of Defense. The awardee, operating under CAGE code 1UNB0, is contracted to deliver this pharmaceutical product without any specified set-aside or NAICS classification. The order is managed under federal procurement protocols, and while the delivery location and point of contact details are not provided, the transaction is documented within the DIBBS system with a public link for record access. The contract reflects a low-value, single-line-item procurement typical for standardized medical supplies within the military healthcare supply chain.
General Info
Agency
Contract Value
$216.48NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
